Division of Pediatric Neurology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Sıhhıye, 06100, Ankara, Turkey.
Department of Medical Genetics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Mol Diagn Ther. 2017 Dec;21(6):643-651. doi: 10.1007/s40291-017-0293-9.
Niemann-Pick disease Type C (NP-C) is a rare, autosomal recessive lysosomal storage disorder caused by mutations in NPC1 or NPC2 genes. Diagnosis of NP-C can be challenging and is frequently delayed. Identifying mutations in individuals with NP-C and their relatives enables genetic counseling and prenatal diagnosis and may support earlier diagnosis. Here we report findings from a prospective cohort study in Turkey, using targeted genetic screening of the families of NP-C probands with homozygous NPC1 or NPC2 mutations.
Probands were selected from a Turkish National Registration Database. Probands had confirmed diagnosis based on NPC1 or NPC2 mutations, with clear indication for consanguineous, homozygous inheritance. Family members were identified from interviews and pedigree analysis. Genetic analysis was performed on DNA from peripheral blood samples from all subjects.
Four probands and 510 individuals from the four families were included. In these four families, the overall NPC1 or NPC2 heterozygous mutation frequency was 22.7%. A novel mutation was identified in NPC1 (p.T375P; c.1123A>C). A previously described NPC2 mutation (p.E118X; c.352G>T) was also observed in two families from different regions of Turkey. We identified two new patients with NP-C from two families.
This is the largest screening study conducted to date in Turkey in the families of patients with NP-C with homozygous inheritance. We have reported heterozygote frequencies, identified a novel mutation, and detected new patients with NP-C. These findings will aid our understanding of NP-C and may lead to improved recognition and more timely diagnosis.
尼曼-匹克病 C 型(NP-C)是一种罕见的常染色体隐性溶酶体贮积症,由 NPC1 或 NPC2 基因突变引起。NP-C 的诊断具有挑战性,且经常延迟。在 NP-C 患者及其亲属中鉴定突变,可进行遗传咨询和产前诊断,并有助于更早诊断。本研究报告了在土耳其进行的一项前瞻性队列研究结果,该研究使用针对 NPC1 或 NPC2 纯合突变 NP-C 先证者的家族进行靶向基因筛查。
从土耳其国家登记数据库中选择先证者。先证者根据 NPC1 或 NPC2 突变确诊,明确提示为近亲、纯合遗传。通过访谈和系谱分析确定家族成员。对所有受试者外周血样本的 DNA 进行基因分析。
纳入了 4 名先证者和来自 4 个家系的 510 名个体。在这 4 个家系中,总体 NPC1 或 NPC2 杂合突变频率为 22.7%。在 NPC1 中发现了一种新突变(p.T375P;c.1123A>C)。在来自土耳其不同地区的两个家系中还观察到了先前描述的 NPC2 突变(p.E118X;c.352G>T)。我们从两个家系中发现了两名新的 NP-C 患者。
这是迄今为止在土耳其针对具有纯合遗传的 NP-C 患者的家族进行的最大规模筛查研究。我们报告了杂合子频率,发现了一种新突变,并检测到两名新的 NP-C 患者。这些发现将有助于我们了解 NP-C,并可能导致更好的识别和更及时的诊断。